NovaBridge Biosciences

NBPNasdaq China Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$201.918 M

$1.75 +2.94%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$46.3M

Loss-making

Shares outstanding

265,377,891

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#265Arcturus TherapeuticsARCT$210.6M
#266Satellos BioscienceMSLE$208.9M
#267NovaBridge BiosciencesNBP$201.9M
#268Minerva NeurosciencesNERV$198.9M
#269PepGenPEPG$197.1M

Where these numbers come from

Share counts and financials for NovaBridge Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.